Real-world predictors of relapse in patients with schizophrenia and schizoaffective disorder in a large health system
Abstract Schizophrenia is often characterized by recurring relapses, which are associated with a substantial clinical and economic burden. Early identification of individuals at the highest risk for relapse in real-world treatment settings could help improve outcomes and reduce healthcare costs. Pri...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-02-01
|
Series: | Schizophrenia |
Online Access: | https://doi.org/10.1038/s41537-024-00448-2 |